Skip to main content
. 2021 Nov 16;11(11):e050880. doi: 10.1136/bmjopen-2021-050880

Table 3.

Associations between provider area of practice and opioid and hydroxyurea utilisation; Sickle Cell Disease (SCD) Implementation Consortium, USA, 2021

Main area of practice
Haematology/SCD Other P value*
Prescribe opioids to patients with SCD
 No 0 (0) 18 (32.7) 0.004
 Yes 17 (100) 37 (67.3)
Comfortable managing hydroxyurea therapy for SCD
 Neutral, somewhat or very uncomfortable 2 (10.5) 25 (49.0) 0.0049
 Somewhat or very comfortable 17 (89.5) 26 (51.0)

*Fisher’s exact test.